What PharmX does

PharmX Technologies Limited (ASX: PHX; OTCMKTS: PHXTF), headquartered in Sydney, Australia, operates the most extensive electronic ordering and invoicing platform for the Australian and New Zealand pharmacy sector. Founded in 2006, the company previously operated as Corum Group before rebranding to Pharmx under CEO Tom Culver in 2023. Its core product, the Gateway, is a cloud-based EDI (Electronic Data Interchange) solution that integrates directly with 18+ pharmacy point-of-sale systems—including Fred, Minfos, Toniq, RxOne, Simple Retail, POSWorks, Pronto, and Corum Health—to automate ordering and e-invoicing between 5,500+ pharmacies and suppliers. A complementary B2B eCommerce Marketplace platform, launched in November 2025, enables multi-vendor product discovery and checkout, and the PharmX Analytics add-on provides predictive modelling, category analytics, natural-language querying, and unrealised-revenue tracking on top of the underlying transaction data.

The business serves two primary customer segments: (i) retail pharmacies across Australia and New Zealand (segment penetration of 99% in Australia per the company), and (ii) pharmaceutical and consumer health suppliers and wholesalers (including Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal, and the major wholesalers CH2, API, and Symbion). Pharmacies access the platform free of charge; revenue is generated via account- and volume-based supplier partnership fees, supplemented by an exclusive contract with the National Diabetes Services Scheme (NDSS) for government diabetes product distribution.

Go-to-market combines self-serve platform access for SMB pharmacies and mid-market suppliers with direct enterprise sales for large pharmacy chains and major brand suppliers. Distribution is anchored by a February 2026 multi-year strategic alliance with Sigma Healthcare, under which Pharmx became the preferred EDI service provider for Sigma's wholesale operations and Chemist Warehouse retail footprint, accompanied by Sigma subscribing for ~10% of Pharmx's issued share capital and obtaining a board seat. The platform processes approximately $20 billion in annual pharmacy transactions across 80,000+ products, with exposure to all major Australian pharmacy banners (Chemist Warehouse, Priceline, Terrywhite Chemmart, Amcal, and Wizard).

Name

PharmX

Legal name

Pharmx Technologies Limited

Website

https://pharmx.com.au

Company type

Public

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

PharmX Technologies (ASX: PHX) operates ANZ's leading pharmacy electronic ordering and invoicing platform, connecting 5,500+ pharmacies and major suppliers via EDI-integrated ordering, a B2B marketplace, and analytics tools, serving 99% of Australian pharmacies.

Ownership category

akta.pro rank

Product category

Pharmacy Supply Chain Software

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)

akta.pro secondary industries

Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK), Pharmacy Benefit Management (PBM) & Pharmacy Network Administration (HLAFALAI)

Keywords

• Pharmacy ordering platform
• Electronic data interchange
• B2B eCommerce marketplace
• Pharmaceutical supply chain
• Point-of-sale integration

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Supplier Partnership Fees: Pharmx's commercial model is funded through account and volume-based fees from supplier partnerships. Some suppliers may pass these fees on to pharmacies at their discretion.
2. Strategic Alliance - Equity Investment: Under the multi-year strategic alliance with Sigma Healthcare, Pharmx receives equity investment (~59.95 million shares representing 10% of issued capital) and pays Sigma an establishment fee of approximately $8.7 million.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

PharmX operates an integrated electronic ordering and invoicing platform for the Australian and New Zealand pharmacy industry. Its core offering is the Gateway, an EDI solution that connects pharmacies and suppliers through point-of-sale systems for automated ordering and e-invoicing. The company also operates a B2B Marketplace for multi-vendor product discovery and checkout, an Analytics platform for supplier insights, and a StockView inventory management tool.

Product overview

PharmX is a platform-plus-modules architecture providing integrated pharmacy ordering solutions across ANZ. The core products are the Gateway (EDI solution connecting pharmacies and suppliers through POS systems for automated ordering and e-invoicing) and the Marketplace (B2B eCommerce platform for product discovery and multi-vendor checkout). The Analytics module builds on these by leveraging the ordering data to deliver actionable insights including unrealised revenue tracking, category performance, and product catalogue enrichment. StockView adds inventory visibility. Together, these solutions facilitate over $20 billion in annual pharmacy transactions and provide access to 80,000+ products across 99% of Australian pharmacies.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 99% of Australian pharmacies use the Pharmx platform
• +5 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration19 records

AI capability5 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Sigma Healthcare LimitedcoreStrategic or Co-development Partner · 23 February 2026Multi-year strategic alliance positioning Pharmx as the preferred EDI service provider for Sigma's wholesale and Chemist Warehouse retail operations across Australia and New Zealand. Under the agreement, Sigma will subscribe for approximately 59.95 million Pharmx shares representing 10% of Pharmx's issued share capital and obtain a board seat. Pharmx will pay Sigma an establishment fee of approximately $8.7 million. The partnership aims to modernise pharmacy supply chains by improving reliability, efficiency, and transparency.
• National Diabetes Services Scheme (NDSS)coreStrategic or Co-development PartnerPharmx holds an exclusive contract with the NDSS, supporting government agency distribution to pharmacies across Australia.
• POS Vendors (Fred, Minfos, Toniq, RxOne, Simple Retail)coreTechnology or IntegrationPharmx integrates with all major point-of-sale vendors in the pharmacy industry including Fred, Minfos, Toniq, RxOne, and Simple Retail for seamless ordering and data synchronization.
• Major Pharmacy Chains (Chemist Warehouse, Priceline, Terrywhite, Amcal, Wizard)coreChannel Partner/ Reseller/ DistributorMajor pharmacy retail chains use Pharmx for ordering and supply chain management including Chemist Warehouse, Priceline, Terrywhite Chemmart, Amcal, and Wizard.
• Major Suppliers (Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal)coreChannel Partner/ Reseller/ DistributorLeading pharmaceutical and consumer health brands distribute through Pharmx including Bayer, Blackmores, Haleon, Pfizer, Reckitt, L'Oréal, and many others.
• Wholesalers (CH2, API, Symbion)coreChannel Partner/ Reseller/ DistributorMajor pharmaceutical wholesalers CH2, API, and Symbion connect to pharmacies through the Pharmx platform.
• Pharmacy Groups (IPA, Chemsave, Chemist King, Discount Drug Stores, Pharmacy 777)minorChannel Partner/ Reseller/ DistributorVarious pharmacy buying groups and banner groups use Pharmx including IPA, Chemsave, Chemist King, Discount Drug Stores, and Pharmacy 777.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• CoverMyMeds: CoverMyMeds (owned by McKesson) operates a leading US electronic prior authorization and benefit verification platform for pharmacies and prescribers. It is a directly comparable two-sided health IT platform monetising pharmacy-supplier-payer connectivity.
• MedAdvisor: MedAdvisor (ASX: MDR) is an Australian digital medication management and patient adherence platform serving pharmacies. It targets the same ANZ pharmacy customer base as PharmX and competes for pharmacy technology wallet share, though focused on patient-facing workflows rather than procurement.
• Surescripts: Surescripts operates the dominant US electronic prescribing network connecting prescribers, pharmacies, payers, and PBMs. Its two-sided health data exchange model and pharmacy-side integration footprint closely mirror PharmX's EDI/marketplace architecture for ANZ pharmacies.
• PDX: PDX provides pharmacy software, clinical programs, and EDI/ordering technology solutions to US independent and chain pharmacies. Its pharmacy-facing ordering and supplier integration stack is functionally analogous to PharmX's Gateway offering.
• RedSail Technologies: RedSail Technologies provides pharmacy management software, clinical solutions, and pharmacy supply chain technology across thousands of US independent pharmacies. Its combined dispensing and procurement technology footprint is closely comparable to PharmX's Gateway-plus-Marketplace model.

Broad incumbents

• McKesson: McKesson is a global pharmaceutical wholesaler and owner of CoverMyMeds, with its own pharmacy ordering and supply chain platforms. It serves as the broad incumbent against which PharmX's ANZ-scale pharmacy network competes in capability breadth if not geographic overlap.
• Cardinal Health: Cardinal Health is a leading US pharmaceutical wholesaler and operator of the OutcomesMTM and pharmacy services platforms. It is comparable as a broad incumbent integrating wholesale distribution with pharmacy technology and analytics.
• Cencora: Cencora (formerly AmerisourceBergen) is a major US pharmaceutical distributor with embedded pharmacy services technology and Good Neighbor Pharmacy provider programs. It represents the broad incumbent equivalent of PharmX's supplier-pharmacy network at global scale.

Emerging players

• RxBenefits: RxBenefits provides PBM technology, pharmacy benefit administration, and pharmacy supply chain analytics to employer health plans. It shares the supplier-pharmacy-payer data monetisation thesis with PharmX but focuses on US benefit administration rather than ordering infrastructure.
• OrderInsite: OrderInsite is a US pharmacy inventory analytics and demand planning vendor serving chain and independent pharmacies. It overlaps with PharmX's newer Analytics/StockView modules, but lacks the EDI and marketplace layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/pharmx

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmX